Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 129.00x is 2738% above its 5-year average of -4.89x, near the high end of its 5-year range (-33.15x–129.00x).
As of the fiscal period ended Tuesday, December 31, 2024. 153.28% above its 12-month average of 50.93x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2024 (2024-12-31): 129.00x.
INTEREST COVERAGE RATIO
129.00x
INTEREST COVERAGE RATIO AVG TTM
50.93x
INTEREST COVERAGE RATIO AVG 3Y
4.20x
INTEREST COVERAGE RATIO AVG 5Y
-4.89x
INTEREST COVERAGE RATIO AVG 10Y
-8.83x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+153.28%
CURRENT VS 3Y AVG
+2969.93%
CURRENT VS 5Y AVG
+2737.63%
CURRENT VS 10Y AVG
+1561.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.97x
median of 298 covered companies
CURRENT VS SECTOR MEDIAN
+4435.98%
vs the sector median at left
BioStem Technologies, Inc.
Market Cap
$46.79M
Interest Coverage Ratio
129.00x
TTM Avg
50.93x
3Y Avg
4.20x
5Y Avg
-4.89x
Market Cap
$45.20M
Interest Coverage Ratio
-11.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$49.40M
Interest Coverage Ratio
3.24x
TTM Avg
3.06x
3Y Avg
3.54x
5Y Avg
8.88x
Market Cap
$49.50M
Interest Coverage Ratio
-9.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.25M
Interest Coverage Ratio
-14.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.51M
Interest Coverage Ratio
-145.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.12M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.41M
Interest Coverage Ratio
-10.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | $46.79M | 129.00x | 50.93x | 4.20x | -4.89x |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | -11.50x | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $49.40M | 3.24x | 3.06x | 3.54x | 8.88x |
| Celularity Inc. (CELU)vs › | $49.50M | -9.08x | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.96M | -8.61x | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -14.01x | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $50.51M | -145.74x | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $42.41M | -10.91x | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A | N/A | N/A | N/A |
Interest Coverage
129.0x
Debt/Equity
0.04
Current Ratio
0.98
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-12-31 | 129.00x |
| 2024-09-30 | 67.10x |
| 2024-06-30 | 40.26x |
| 2024-03-31 | 28.11x |
| 2023-12-31 | -9.82x |
| 2023-09-30 | 3.27x |
| 2023-06-30 | -18.97x |
| 2023-03-31 | -13.17x |
| 2022-12-31 | -33.15x |
| 2022-09-30 | -7.01x |
| 2022-06-30 | 3.56x |
| 2022-03-31 | -5.47x |
| 2021-12-31 | -4.29x |
| 2021-09-30 | -6.23x |
| 2021-06-30 | -1.74x |
| 2021-03-31 | -3.40x |
| 2020-12-31 | -3.41x |
| 2020-09-30 | -4.30x |
| 2020-06-30 | -4.30x |
| 2020-03-31 | -1.92x |
| 2019-12-31 | -1.05x |
| 2019-09-30 | -8.97x |
| 2019-06-30 | -14.47x |
| 2019-03-31 | -17.94x |
| 2018-12-31 | -8.06x |
| 2018-09-30 | -33.34x |
| 2015-12-31 | -122.32x |
| 2015-09-30 | -108.06x |
| 2015-06-30 | -232.92x |
